Company Update2 Min Read InvestyWise NewsonOctober 23, 2025 Choice Expands Wealth Management with Multiple Acquisitions, Adds ₹635 Crore AUM Choice International has strategically expanded its wealth management segment through multiple acquisitions, adding approximately ₹635 Crore…
Company Update1 Min Read InvestyWise NewsonOctober 23, 2025 Aurobindo Pharma Eugia Pharma Expands with New Chile Subsidiary Aurobindo Pharma announced that Eugia Pharma B.V., its wholly owned stepdown subsidiary, has incorporated a new wholly owned subsidiary in…
Company Update1 Min Read InvestyWise NewsonOctober 23, 2025 Aurobindo Pharma Incorporates New Subsidiary in Chile Aurobindo Pharma has announced the incorporation of a new wholly-owned subsidiary in Chile, named Aurobindo Pharma Chile SpA. This entity was…
Company Update1 Min Read InvestyWise NewsonOctober 23, 2025 Kalpataru Projects Secures New Orders Worth ₹2,332 Crores Kalpataru Projects International Limited (KPIL) and its subsidiaries have secured new orders totaling approximately ₹2,332 Crores. These…
Company Update1 Min Read InvestyWise NewsonOctober 23, 2025 Glenmark US Arm to Launch Ropivacaine Hydrochloride Injection Glenmark Pharmaceuticals Inc., USA, is set to launch Ropivacaine Hydrochloride Injection USP in various dosages: 40 mg/20 mL (2mg/mL), 150…
Company Update1 Min Read InvestyWise NewsonOctober 23, 2025 Hyundai Motor India Appoints Sunil Moolchandani as National Sales Head Hyundai Motor India Limited (HMIL) has appointed Sunil Moolchandani as the Function Head – National Sales. With over two decades of…
Company Update2 Min Read InvestyWise NewsonOctober 23, 2025 Tejas Networks To Supply IP/MPLS Routers for BharatNet Phase III Tejas Networks has been selected to supply IP/MPLS Routers for multiple packages of the BharatNet Phase III project. Tejas will partner with…
Company Update2 Min Read InvestyWise NewsonOctober 23, 2025 Biocon Biologics Health Canada Approves Yesintek, Biosimilar to Stelara Biocon Biologics has received Health Canada approval for Yesintek™ (ustekinumab injection) and Yesintek™ I.V., biosimilars to Stelara®. This…
Board Meeting1 Min Read InvestyWise NewsonOctober 22, 2025 OLA Electric Board to Consider Raising Funds OLA Electric has announced that a meeting of its Board of Directors will convene on October 25, 2025, to consider and approve a proposal for…
Company Update1 Min Read InvestyWise NewsonOctober 22, 2025 Max Healthcare Company Assigned ESG Rating of ’74’ by CFC Finlease Max Healthcare Institute Limited has received an ESG rating of ’74’ from CFC Finlease Private Limited, a SEBI registered ESG…